glp-1 news oct 21 2025 Alarming rise in weight loss drug overdoses GLP-1 Agonists Market Report 2025-2033,

This works by suppressing pro-inflammatory cytokines like IL-6 and TNF-alpha, molecules commonly elevated in men with chronic joint pain and autoimmune conditions such as rheumatoid arthritis

The manufacturers' patient information leaflets (PILs) and Summaries of Product Characteristics (SmPCs) provide clear guidance on approved injection sites to optimise treatment outcomes and patient safety

It is not a prohibited substance and has previously been used in drink form

Your physician will design an integrated treatment plan that maximizes cosmetic, metabolic, and longevity outcomes while ensuring safety across all modalities